Parrini Elena, Ferrari Anna Rita, Dorn Thomas, Walsh Christopher A, Guerrini Renzo
Pediatric Neurology and Neurogenetics Unit, Children's Hospital A. Meyer-University of Florence, Florence, Italy.
Epilepsia. 2009 Jun;50(6):1344-53. doi: 10.1111/j.1528-1167.2008.01787.x. Epub 2008 Oct 6.
Bilateral frontoparietal polymicrogyria (BFPP) has been reported in sporadic patients and in recessive pedigrees. Eleven mutations in GPR56, a gene encoding an evolutionarily dynamic G-protein-coupled receptor, have been identified in 29 patients from 18 families. The clinical features of BFPP include severe mental retardation, motor and language impairment, and epilepsy. No detailed description of the epilepsy is available for the patients reported to date. We report three consanguineous families in which four affected individuals with BFPP and GPR56 mutations had Lennox-Gastaut syndrome.
Family studies, brain magnetic resonance imaging (MRI), electroencephalography (EEG)-video recordings, and mutation analysis.
In Family 1, with one affected proband, we found an R565W change in the second extracellular loop of GPR56, involving a highly conserved aminoacidic residue. In Family 2, with one affected proband, we found an R79X change affecting the protein N-terminus and predicted to cause a premature truncation with loss of the G-protein-coupled receptor proteolytic site. In family 3, with two affected siblings, we found an R33P substitution in the protein N-terminus, involving a highly conserved aminoacidic residue. Epilepsy, present in all four patients, had started between ages 1 and 8 years, with infantile spasms in one patient and with de novo Lennox-Gastaut syndrome in the remaining three. All patients had Lennox-Gastaut syndrome when last observed, at ages 13 to 32 years.
Several genes, when mutated, can cause malformations of cortical development that have been associated with the Lennox-Gastaut syndrome. BFPP caused by GPR56 mutations represents an additional, although rare, genetically determined cause of Lennox-Gastaut syndrome.
散发性患者及隐性遗传家系中均有双侧额顶叶多小脑回(BFPP)的报道。在来自18个家系的29例患者中已鉴定出GPR56基因的11种突变,该基因编码一种进化上具有动态变化的G蛋白偶联受体。BFPP的临床特征包括严重智力发育迟缓、运动及语言障碍和癫痫。对于迄今报道的患者,尚无关于癫痫的详细描述。我们报告了3个近亲家系,其中4例患有BFPP且携带GPR56突变的患者患有Lennox-Gastaut综合征。
家系研究、脑磁共振成像(MRI)、脑电图(EEG)-视频记录及突变分析。
在家族1中,有1例患病先证者,我们在GPR56的第二个细胞外环中发现R565W改变,涉及一个高度保守的氨基酸残基。在家族2中,有1例患病先证者,我们发现R79X改变影响蛋白质N端,并预计会导致蛋白质过早截断,失去G蛋白偶联受体蛋白水解位点。在家族3中,有2例患病同胞,我们在蛋白质N端发现R33P替代,涉及一个高度保守的氨基酸残基。所有4例患者均有癫痫发作,起病年龄在1至8岁之间,1例患者有婴儿痉挛症,其余3例新发Lennox-Gastaut综合征。最后一次观察时,所有患者年龄在13至32岁,均患有Lennox-Gastaut综合征。
几个基因发生突变时可导致与Lennox-Gastaut综合征相关的皮质发育畸形。由GPR56突变引起的BFPP是Lennox-Gastaut综合征另一种虽罕见但由遗传决定的病因。